Why the study?
Does intravenous ajmaline alter right ventricular monophasic action potentials in a patient with Brugada syndrome?
Population
1 48-year-old patient with recurrent episodes of palpitations and syncope, transient ST segment elevation in…
Design
Case_report
Authors
Loading...
Ajmaline-induced RV repolarization changes may underlie Brugada ECG patterns; single-case data leave mechanistic confirmation open.
Does intravenous ajmaline alter right ventricular monophasic action potentials in a patient with Brugada syndrome?
Intravenous ajmaline induces regionally different action potential changes in the right ventricle, which may contribute to the characteristic ECG changes seen in Brugada syndrome.
ECKARDT et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: